Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Bernstein Initiates Coverage on Swiggy and Zomato with 'Outperform' Ratings and Price Targets

Brokerage Reports

|

Updated on 04 Nov 2025, 06:06 am

Whalesbook Logo

Reviewed By

Akshat Lakshkar | Whalesbook News Team

Short Description :

US-based brokerage Bernstein has started covering Indian companies Swiggy and Zomato (Eternal), rating both as 'Outperform'. Bernstein set price targets of ₹570 for Swiggy and ₹390 for Zomato, believing they are best positioned to benefit from India's growing digital consumption in food delivery and quick commerce. The report highlights the affluent Indian consumer segment willing to pay for convenience as a key growth driver.
Bernstein Initiates Coverage on Swiggy and Zomato with 'Outperform' Ratings and Price Targets

▶

Stocks Mentioned :

Zomato Limited

Detailed Coverage :

Bernstein, a US brokerage, has initiated coverage on Indian companies Swiggy and Zomato (Eternal) with an 'Outperform' rating and set target prices of ₹570 for Swiggy and ₹390 for Zomato. They are seen as best positioned to capture value in India's fast-growing food delivery (FD) and quick commerce (QC) markets. A key growth driver is the affluent Indian segment ('Top-5 per cent Lifestyle Concierges') willing to pay for convenience, representing an $80 billion opportunity by FY2030. Expansion into dining out, events, and ticketing is expected. While QC is competitive, it's not a "winner-takes-all" market, with leaders like Blinkit, Instamart, and Zepto expected to remain profitable. FD remains the "cash machine," with future growth from innovation, though margins are expected to be stable. Bernstein views Swiggy as its top pick due to its Instamart performance and profitability path.

**Impact**: This news is likely to boost investor confidence in Swiggy and Zomato, potentially driving their stock prices towards the set targets. The detailed market analysis may also attract broader interest in the Indian tech and consumer sectors. Impact Rating: 8/10

**Heading: Difficult Terms and Their Meanings** **Brokerage**: A firm that helps investors buy and sell securities. **Initiated Coverage**: Began regularly publishing research and recommendations on a company. **Outperform**: A rating suggesting a stock will perform better than the market average. **Target Price (TP)**: Analyst's projection of a stock's future price. **Food Delivery (FD)**: Service of delivering meals from restaurants. **Quick Commerce (QC)**: Extremely fast delivery service (often within minutes). **GDP per capita**: Gross Domestic Product divided by the population, indicating economic output per person. **FY (Fiscal Year)**: A 12-month accounting period (India: April 1 - March 31). **Mom-and-pop stores**: Small, independently owned businesses. **Scale Effects**: Cost advantages due to a company's size. **Network Effects**: A product/service becomes more valuable as more people use it. **Profitability Glide Path**: A projected timeline for a company to become profitable. **Bourses**: Stock exchange. **Sensex**: A BSE index of 30 major Indian companies.

More from Brokerage Reports

3 ‘Buy’ recommendations by Motilal Oswal, with up to 28% upside potential

Brokerage Reports

3 ‘Buy’ recommendations by Motilal Oswal, with up to 28% upside potential

Who Is Dr Aniruddha Malpani? IVF Specialist And Investor Alleges Zerodha 'Scam' Over Rs 5-Cr Withdrawal Issue

Brokerage Reports

Who Is Dr Aniruddha Malpani? IVF Specialist And Investor Alleges Zerodha 'Scam' Over Rs 5-Cr Withdrawal Issue

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Brokerage Reports

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Stocks to buy: Raja Venkatraman's top picks for 4 November

Brokerage Reports

Stocks to buy: Raja Venkatraman's top picks for 4 November

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Brokerage Reports

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Bernstein initiates coverage on Swiggy, Eternal with 'Outperform'; check TP

Brokerage Reports

Bernstein initiates coverage on Swiggy, Eternal with 'Outperform'; check TP


Latest News

Whirlpool India Q2 net profit falls 21% to ₹41 crore on lower revenue, margin pressure

Consumer Products

Whirlpool India Q2 net profit falls 21% to ₹41 crore on lower revenue, margin pressure

Is India's tax system fueling the IPO rush? Zerodha's Nithin Kamath thinks so

Economy

Is India's tax system fueling the IPO rush? Zerodha's Nithin Kamath thinks so

Ambuja Cements aims to lower costs, raise production by 2028

Industrial Goods/Services

Ambuja Cements aims to lower costs, raise production by 2028

Women cricketers see surge in endorsements, closing in the gender gap

Consumer Products

Women cricketers see surge in endorsements, closing in the gender gap

Earning wrap today: From SBI, Suzlon Energy and Adani Enterprise to Indigo, key results announced on November 4

Economy

Earning wrap today: From SBI, Suzlon Energy and Adani Enterprise to Indigo, key results announced on November 4

‘Builders’ luxury focus leads to supply crunch in affordable housing,’ D Lakshminarayanan MD of Sundaram Home Finance

Banking/Finance

‘Builders’ luxury focus leads to supply crunch in affordable housing,’ D Lakshminarayanan MD of Sundaram Home Finance


Auto Sector

Norton unveils its Resurgence strategy at EICMA in Italy; launches four all-new Manx and Atlas models

Auto

Norton unveils its Resurgence strategy at EICMA in Italy; launches four all-new Manx and Atlas models

SUVs toast of nation, driving PV sales growth even post GST rate cut: Hyundai

Auto

SUVs toast of nation, driving PV sales growth even post GST rate cut: Hyundai

Farm leads the way in M&M’s Q2 results, auto impacted by transition in GST

Auto

Farm leads the way in M&M’s Q2 results, auto impacted by transition in GST

Tesla is set to hire ex-Lamborghini head to drive India sales

Auto

Tesla is set to hire ex-Lamborghini head to drive India sales

Mahindra in the driver’s seat as festive demand fuels 'double-digit' growth for FY26

Auto

Mahindra in the driver’s seat as festive demand fuels 'double-digit' growth for FY26

Mahindra & Mahindra’s profit surges 15.86% in Q2 FY26

Auto

Mahindra & Mahindra’s profit surges 15.86% in Q2 FY26


Healthcare/Biotech Sector

Stock Crash: Blue Jet Healthcare shares tank 10% after revenue, profit fall in Q2

Healthcare/Biotech

Stock Crash: Blue Jet Healthcare shares tank 10% after revenue, profit fall in Q2

Novo sharpens India focus with bigger bets on niche hospitals

Healthcare/Biotech

Novo sharpens India focus with bigger bets on niche hospitals

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Healthcare/Biotech

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

Healthcare/Biotech

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

More from Brokerage Reports

3 ‘Buy’ recommendations by Motilal Oswal, with up to 28% upside potential

3 ‘Buy’ recommendations by Motilal Oswal, with up to 28% upside potential

Who Is Dr Aniruddha Malpani? IVF Specialist And Investor Alleges Zerodha 'Scam' Over Rs 5-Cr Withdrawal Issue

Who Is Dr Aniruddha Malpani? IVF Specialist And Investor Alleges Zerodha 'Scam' Over Rs 5-Cr Withdrawal Issue

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Stocks to buy: Raja Venkatraman's top picks for 4 November

Stocks to buy: Raja Venkatraman's top picks for 4 November

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Bernstein initiates coverage on Swiggy, Eternal with 'Outperform'; check TP

Bernstein initiates coverage on Swiggy, Eternal with 'Outperform'; check TP


Latest News

Whirlpool India Q2 net profit falls 21% to ₹41 crore on lower revenue, margin pressure

Whirlpool India Q2 net profit falls 21% to ₹41 crore on lower revenue, margin pressure

Is India's tax system fueling the IPO rush? Zerodha's Nithin Kamath thinks so

Is India's tax system fueling the IPO rush? Zerodha's Nithin Kamath thinks so

Ambuja Cements aims to lower costs, raise production by 2028

Ambuja Cements aims to lower costs, raise production by 2028

Women cricketers see surge in endorsements, closing in the gender gap

Women cricketers see surge in endorsements, closing in the gender gap

Earning wrap today: From SBI, Suzlon Energy and Adani Enterprise to Indigo, key results announced on November 4

Earning wrap today: From SBI, Suzlon Energy and Adani Enterprise to Indigo, key results announced on November 4

‘Builders’ luxury focus leads to supply crunch in affordable housing,’ D Lakshminarayanan MD of Sundaram Home Finance

‘Builders’ luxury focus leads to supply crunch in affordable housing,’ D Lakshminarayanan MD of Sundaram Home Finance


Auto Sector

Norton unveils its Resurgence strategy at EICMA in Italy; launches four all-new Manx and Atlas models

Norton unveils its Resurgence strategy at EICMA in Italy; launches four all-new Manx and Atlas models

SUVs toast of nation, driving PV sales growth even post GST rate cut: Hyundai

SUVs toast of nation, driving PV sales growth even post GST rate cut: Hyundai

Farm leads the way in M&M’s Q2 results, auto impacted by transition in GST

Farm leads the way in M&M’s Q2 results, auto impacted by transition in GST

Tesla is set to hire ex-Lamborghini head to drive India sales

Tesla is set to hire ex-Lamborghini head to drive India sales

Mahindra in the driver’s seat as festive demand fuels 'double-digit' growth for FY26

Mahindra in the driver’s seat as festive demand fuels 'double-digit' growth for FY26

Mahindra & Mahindra’s profit surges 15.86% in Q2 FY26

Mahindra & Mahindra’s profit surges 15.86% in Q2 FY26


Healthcare/Biotech Sector

Stock Crash: Blue Jet Healthcare shares tank 10% after revenue, profit fall in Q2

Stock Crash: Blue Jet Healthcare shares tank 10% after revenue, profit fall in Q2

Novo sharpens India focus with bigger bets on niche hospitals

Novo sharpens India focus with bigger bets on niche hospitals

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure